Aquestive Therapeutics, Inc. Public Float
Aquestive Therapeutics, Inc. (AQST) had Public Float of $291.60 million as of 2025-06-30, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-04
- 2025-06-30: Entity Public Float $291.60M.
- 2024-06-28: Entity Public Float $207.30M.
- 2023-06-30: Entity Public Float $82.70M.
- 2022-06-30: Entity Public Float $27.60M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $291.60M 10-K · filed 2026-03-04 |
| 2024-06-28 | $207.30M 10-K · filed 2025-03-05 |
| 2023-06-30 | $82.70M 10-K · filed 2024-03-05 |
| 2022-06-30 | $27.60M 10-K · filed 2023-03-31 |
| 2021-06-30 | $110.70M 10-K · filed 2022-03-08 |
| 2020-06-30 | $102.30M 10-K · filed 2021-03-09 |
| 2019-06-30 | $101.00M 10-K · filed 2020-03-11 |
| 2019-03-08 | $101.00M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |